Illumina (ILMN)
(Delayed Data from NSDQ)
$94.66 USD
-8.05 (-7.84%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $94.98 +0.32 (0.34%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Fundamental Charts
About Dividend Yield (TTM)
Illumina, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ILMN 94.66 -8.05(-7.84%)
Will ILMN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ILMN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ILMN
Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key Metrics
Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates
ILMN: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Genomics Stocks Worth Adding to Your Portfolio in 2025
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics
CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Other News for ILMN
Illumina price target raised by $10 at Morgan Stanley, here's why
Cathie Wood's Ark Invest Loads Up On Coinbase, Roku, Illumina, And Bitmine Immersion
Decoding Illumina Inc (ILMN): A Strategic SWOT Insight
Illumina (ILMN) Surpasses Q2 Targets and Boosts 2025 Outlook
Illumina raises 2025 revenue and EPS guidance as clinical demand strengthens and multiomics acquisition advances